SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-05-029084
Filing Date
2005-09-16
Accepted
2005-09-16 17:02:59
Documents
9
Period of Report
2005-09-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v025810_8k.htm 8-K 36123
2 v025810_ex10-1.htm EX-10.1 394960
3 v025810_ex10-2.htm EX-10.2 44306
4 v025810_ex10-3.htm EX-10.3 219970
5 v025810_ex10-4.htm EX-10.4 157369
6 v025810_ex10-5.htm EX-10.5 54880
7 v025810_ex10-6.htm EX-10.6 54326
8 v025810_ex10-7.htm EX-10.7 159281
9 v025810_ex10-8.htm EX-10.8 120241
  Complete submission text file 0001144204-05-029084.txt   1243091
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 051089522
SIC: 2834 Pharmaceutical Preparations